Found: 7
Select item for more details and to access through your institution.
A prospective study to validate the functional assessment of cancer therapy (FACT) for epidermal growth factor receptor inhibitor (EGFRI)-induced dermatologic toxicities FACT-EGFRI 18 questionnaire: SWOG S1013.
- Published in:
- Journal of Patient-Reported Outcomes, 2020, v. 4, n. 1, p. 1, doi. 10.1186/s41687-020-00220-x
- By:
- Publication type:
- Article
Patient-Reported Symptoms and Quality of Life During Treatment With Tamoxifen or Raloxifene for Breast Cancer Prevention.
- Published in:
- JAMA: Journal of the American Medical Association, 2006, v. 295, n. 23, p. 2742, doi. 10.1001/jama.295.23.joc60075
- By:
- Publication type:
- Article
Effects of Tamoxifen vs Raloxifene on the Risk of Developing Invasive Breast Cancer and Other Disease Outcomes.
- Published in:
- JAMA: Journal of the American Medical Association, 2006, v. 295, n. 23, p. 2727, doi. 10.1001/jama.295.23.joc60074
- By:
- Publication type:
- Article
Two-Year Trends of Taxane-Induced Neuropathy in Women Enrolled in a Randomized Trial of Acetyl-L-Carnitine (SWOG S0715).
- Published in:
- 2018
- By:
- Publication type:
- journal article
Long-term Peripheral Neuropathy in Breast Cancer Patients Treated With Adjuvant Chemotherapy: NRG Oncology/NSABP B-30.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2018, v. 110, n. 2, p. 1, doi. 10.1093/jnci/djx162
- By:
- Publication type:
- Article
Effective stakeholder engagement: design and implementation of a clinical trial (SWOG S1415CD) to improve cancer care.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Phase II Trial of Simple Oral Therapy with Capecitabine and Cyclophosphamide in Patients with Metastatic Breast Cancer: SWOG S0430.
- Published in:
- Oncologist, 2012, v. 17, n. 2, p. 179, doi. 10.1634/theoncologist.2011-0235
- By:
- Publication type:
- Article